The mechanism by which serglycin alters tumor cell aggressiveness is still elusive, however differential expression of serglycin seems to affect the expression levels of markers of epithelial to mesenchymal transition both in vitro and in vivo [3–5]. This evidence concerns the gene SRGN and neoplasm.